These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 28974498
1. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients. Obokata M, Negishi K, Sunaga H, Ishida H, Ito K, Ogawa T, Iso T, Ando Y, Kurabayashi M. J Am Heart Assoc; 2017 Oct 03; 6(10):. PubMed ID: 28974498 [Abstract] [Full Text] [Related]
5. Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients. Ok ES, Asci G, Toz H, Ritz E, Kircelli F, Sever MS, Ozkahya M, Sipahi S, Dheir H, Bozkurt D, Omer Z, Sahin OZ, Ertilav M, Ok E. Clin Nephrol; 2014 Sep 03; 82(3):173-80. PubMed ID: 25079862 [Abstract] [Full Text] [Related]
6. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy. Hayashi T, Kimura T, Yasuda K, Sasaki K, Obi Y, Rakugi H, Isaka Y. Clin Exp Nephrol; 2017 Apr 03; 21(2):333-341. PubMed ID: 27178276 [Abstract] [Full Text] [Related]
8. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD. Kennedy DJ, Fan Y, Wu Y, Pepoy M, Hazen SL, Tang WH. Clin J Am Soc Nephrol; 2014 Mar 03; 9(3):462-7. PubMed ID: 24311705 [Abstract] [Full Text] [Related]
9. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population. Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J. Clin Interv Aging; 2016 Mar 03; 11():245-53. PubMed ID: 27013868 [Abstract] [Full Text] [Related]
10. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease. Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P. Atherosclerosis; 2013 Jun 03; 228(2):478-84. PubMed ID: 23582589 [Abstract] [Full Text] [Related]
13. Effect of the arteriovenous access for hemodialysis on subendocardial viability ratio, pulse pressure and hospitalizations. Vizinho RS, Santos C, Lucas C, Adragão T, Barata JD. J Nephrol; 2014 Oct 03; 27(5):563-70. PubMed ID: 24599828 [Abstract] [Full Text] [Related]
14. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study. Mandai S, Kanda E, Iimori S, Naito S, Noda Y, Kikuchi H, Akazawa M, Oi K, Toda T, Sohara E, Okado T, Sasaki S, Rai T, Uchida S. Clin Exp Nephrol; 2017 Feb 03; 21(1):104-111. PubMed ID: 27039905 [Abstract] [Full Text] [Related]
15. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study. Mitsuma W, Matsubara T, Hatada K, Imai S, Saito N, Shimada H, Miyazaki S. J Cardiol; 2016 Aug 03; 68(2):148-55. PubMed ID: 26527113 [Abstract] [Full Text] [Related]
17. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, Vanholder R, Diouf M, Choukroun G, Massy ZA, European Uremic Toxin Work Group (EUTox). Kidney Int; 2012 Dec 03; 82(12):1297-303. PubMed ID: 22895515 [Abstract] [Full Text] [Related]
18. Peripheral endothelial function and cardiovascular events in high-risk patients. Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, Matsubara J, Kurokawa H, Fujisue K, Konishi M, Akiyama E, Suzuki H, Nagayoshi Y, Yamamuro M, Sakamoto K, Iwashita S, Jinnouchi H, Taguri M, Morita S, Matsui K, Kimura K, Umemura S, Ogawa H. J Am Heart Assoc; 2013 Nov 25; 2(6):e000426. PubMed ID: 24275629 [Abstract] [Full Text] [Related]
19. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD. Clin J Am Soc Nephrol; 2013 Dec 25; 8(12):2132-40. PubMed ID: 24052218 [Abstract] [Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. Patton KK, Sotoodehnia N, DeFilippi C, Siscovick DS, Gottdiener JS, Kronmal RA. Heart Rhythm; 2011 Feb 25; 8(2):228-33. PubMed ID: 21044699 [Abstract] [Full Text] [Related] Page: [Next] [New Search]